Universal Medical Financial & Technical Advisory Services Company Limited is successfully listed in the main board of Hong Kong Exchange, abbreviated as “Universal Medical”, code number 2666 on July 8, 2015.

At 8:30 am, July 8, 2015, Universal Medical welcomed its grand listing ceremony at Hong Kong Exchange. During the event, Ms. Li Dang, General Manager of China General Technology (Group) Holding, Limited and Mr. Zhang Yichen, President of Citic Captial Holdings Limited and Chairman of Universal Medical knocked the gong and started the stock trading. The other leaders that attended the ceremony were Mr. Jiang Xin, Chief Accountant and Vice Chairman of Universal Medical, Mr. Luo Xiaofang, Secretary of Group Board and Assistant to General Manager, Mr. Guo Weiping, CEO and Executive Director of Universal Medical and Ms. Peng Jiahong, CFO and Executive Director. Representatives of shareholders and agencies, cornerstone investors, medical experts from both home and abroad, senior staff of Universal Medical and staff representatives, altogether 60 of them also witnessed this great moment of Universal Medical.

The IPO has received great resonance from world market and was 52 times oversubscribed. Universal Medical’s cornerstone investors include: CSR (Hong Kong) Limited, Nikko Asset Management, E Fund Management, GF Fund Management, Beijing Cihang Investment Management, Beijing Infrastructure Investment (Hong Kong), Guangdong Hengjian Investment Holding, Heywin Investments Limited. Cornerstone investors subscribed USD 200 million. Hong Kong IPO’s final share number is 169,276,000 and the final number of international placing shares is 253,913,500.

The successful IPO is an important milestone in Universal Medical’s company history, which will bring more opportunities and momentums for its future development. During previous road show, Universal Medical has attracted extensive attention and support from global investors. Its strategic model, growing potential and management capability have won recognition from all the parties. In the future, Universal Medical will make promoting China’s healthcare development as its own responsibility. The company will continue to expand healthcare platform resources, consolidate development foundation, and deepen professional services to create consistently growing value for shareholders and investors.